Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-044186
Filing Date
2014-06-27
Accepted
2014-06-27 17:31:53
Documents
2
Period of Report
2014-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6188
2 POA DOCUMENT poa.txt EX-24.4_529495 3027
  Complete submission text file 0001209191-14-044186.txt   10540
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
BONDERMAN DAVID (Reporting) CIK: 0000860866 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36508 | Film No.: 14946751

Mailing Address 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address 2225 COLORADO AVENUE SANTA MONICA CA 90404 (310) 824-9999
Kite Pharma, Inc. (Issuer) CIK: 0001510580 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)